Thrombectomy Devices

This channel includes news and new technology innovations for catheter-based thrombectomy systems used to remove blood clots from vessels in the body. Thrombus removal a decade ago was a standard of care for acute coronary revascularization in ST-elevation myocardial infarction (STEMI). But, its use declined rapidly after several large trials showed no benefit. However today, thrombectomy is seeing increasing usage in new therapeutic areas to treat acute stoke, pulmonary embolism (PE), deep vein thrombosis (DVT) and venous thromboembolism (VTE). Thrombectomy is also referred to as embolectomy.

The types of thrombectomy systems include: 

   ● Ultrasound-assisted thrombolysis – Catheter-directed, high-frequency ultrasound helps thrombolytic agents penetrate clots to speed the action of fibrinolytic pharmacological therapy. 

   ● Rheolytic embolectomy – These devices inject pressurized saline through the catheter's distal tip and the macerated thrombus is aspirated through a catheter port. 

   ● Rotational embolectomy – A rotating device at the catheter tip is used to fragment the clot and fragments are aspirated by the catheter. 

   ● Aspiration thrombectomy – This includes manual clot aspiration or use of dedicated aspiration catheter devices that basically vacuum the clot out of the vessel. 

   ● Thrombus fragmentation – Thrombus can be mechanically disrupted by manually rotating a pigtail catheter or using balloon angioplasty, but this causes small fragments of emboli to flow distally. Dedicated devices also are available.

News | Stroke

Oct. 8, 2026 — Government officials, global health leaders, clinicians, patient advocates, professional societies and ...

Home October 08, 2026
Home
News | Cardiovascular Business

Oct. 5, 2026 – Endologix Holdings, LLC has announced Rhevera Medical as its new corporate brand. The new identity ...

Home October 05, 2026
Home
News | Thrombectomy Devices

Sept. 8, 2026 — Penumbra recently launched the Link clot capture device designed to support the removal of arterial ...

Home September 15, 2026
Home
News | Thrombectomy Devices

 Aug. 29, 2026— Vesalio recently announced results from the NATURE trial (NCT04969471), a prospective, randomized ...

Home September 10, 2026
Home
News | Stroke

Aug. 20, 2026 — The Advanced Research Projects Agency for Health (ARPA-H) has awarded Siemens Healthineers up to $31.1 ...

Home August 20, 2026
Home
News | Stroke

July 22, 2026 — Penumbra, Inc. recently announced the results of Thunder, an Investigational Device Exemption (IDE) ...

Home July 27, 2026
Home
News | Thrombectomy Devices

July 21, 2026 — Vesalio recently announced that the results from the randomized NATURE clinical trial evaluating the ...

Home July 21, 2026
Home
News | Guidewires

July 16, 2026 — Imperative Care has introduced the Ikon 24 Pro Guidewire, a neurovascular guidewire purpose-built to ...

Home July 17, 2026
Home
News | FDA

June 15, 2006 — Penumbra, Inc. has secured the CE Mark in Europe for Thunderbolt, further laying the groundwork for ...

Home June 15, 2026
Home
News | Thrombectomy Devices

June 11, 2026— Penumbra, Inc. has received U.S. Food and Drug Administration (FDA) clearance for Thunderbolt, expanding ...

Home June 12, 2026
Home
Feature | Thrombectomy Devices

Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...

Home June 01, 2026
Home
News | Pulmonary Embolism

April 13, 2026 — Penumbra, Inc.  announced 90-day results of the landmark STORM-PE randomized controlled trial (RCT) ...

Home April 13, 2026
Home
News | Thrombectomy Devices

March 19, 2026 — Endovascular Engineering, Inc. has announced that two abstracts related to the ENGULF study and the ...

Home March 20, 2026
Home
News | Stroke

Feb. 6, 2026 — Rapid Medical, a developer of active endovascular devices, has announced the latest results from the ...

Home February 10, 2026
Home
News | Stroke

Feb. 2, 2026 — Brainomix, a provider of AI-powered imaging tools in stroke and lung fibrosis, is introducing its new ...

Home February 02, 2026
Home
Subscribe Now